1. Abildgaard, U. 1979. Evidence that antithrombin III is the main physiological inhibitor of coagulation enzymes. In: D.Collen, B.Wiman and M.Verstraete (eds.), The Physiological Inhibitors of Blood Coagulation and Fibrinolysis, (Elsevier/North Holland, Amsterdam) 31?33
2. Bachmann, F. and Kruithof, I.E.K.O. 1984. Tissue plasminogen activator: chemical and physiological aspects. Seminars in Thrombosis and Hemostasis, 10, 6?17
3. Basu, D., Gallus, A., Hirsh, J. and Code, J. (1972)_. A prospective study of the value of monitoring hepa treatment with the activated partial thromboplastin time. The New England Journal of Medicine, 287, 324?327
4. Bernard, W., Morris, D.D., Divers, T.J. and Ramberg, C. 1987. Plasma antithrombin-III values in healthy horses: Effect of sex and/or breed. American Journal of Veterinary Research, 48, 866?868
5. Bick, R.L. 1981. Clinical relevance of antithrombin III. Seminars in Thrombosis and Hemostasis, 7, 263?269